What’s New in Dermatology with Dr. Ashley Bourgeois, DACVD

Cost

Free/Sponsored

Related Disciplines:

December 2024

In today’s VETgirl online veterinary CE podcast, we talk to Dr. Ashley Bourgeois, DACVD on what’s new in veterinary dermatology? Tune in to learn the biggest challenges veterinarians face when managing allergies in dogs, and when you should reach for Cytopoint, a JAK inhibitor, steroids, cyclosporine, or other prescription medications! Learn if you should be carrying more than one JAK inhibitor now that there is a second one available, and how to communicate with your pet owners about the use of JAK inhibitors!

Today’s VETgirl podcast is brought to you by Elanco, makers of Zenrelia™ (ilunocitinib tablets). Get dogs back to normal with the once-daily JAK inhibitor for dogs over 12 months of age with allergic dermatitis and atopic dermatitis. For more information, visit my.elanco.com/us/zenrelia.

INDICATIONS   
Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

IMPORTANT SAFETY INFORMATION
Read the entire package insert before using this drug, including the Boxed Warning.
For Full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination.
Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to opportunistic infections. Neoplastic conditions (benign and malignant) were observed during clinical studies. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert.

Elanco logo

Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2024 Elanco or its affiliates. PM-US-24-2108(2)

Today’s VETgirl podcast is sponsored by Elanco. Please note the opinions in this podcast are the expressed opinion of the speaker(s)/sponsor, and not directly endorsed by VETgirl. Please note: Dr. Ashley Bourgeois, DACVD was compensated for this podcast.

Not a VETgirl ELITE member? Get your learning on with the #1 veterinary CE resource – clinically relevant, practical, and accessible 24/7 on your own time! Don’t miss out – click HERE to check out your options, including our new  14-day, no-commitment ELITE Trial.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!